Hot or Nothing
See My Plan
Woman's hands holding a ceramic cup of tea on a rustic wooden stool beside a vase

Does Low-Dose Tirzepatide with Metformin Keep Weight Off?

Can combining low-dose tirzepatide with metformin help sustain weight loss and insulin sensitivity during maintenance?

Reviewed by Taylor Anderson, RN

Aesthetic Registered Nurse

Taylor Anderson is an aesthetic registered nurse and a reviewer for Hot or Nothing.

Updated October 21, 2026

Quick answer

Low-dose tirzepatide keeps weight off for some women but not for all of them. In the SURMOUNT-MAINTAIN trial, people who stepped down to 5 mg of tirzepatide after their weight plateaued kept an average of 67.9% of the weight they had lost, but only 42.4% kept at least 80% of it. Metformin was not tested in the tirzepatide maintenance trials, so the evidence supports finding the tirzepatide dose that holds your weight, not adding metformin.

In this guide

Key takeaways

  • In the SURMOUNT-4 trial, people who stopped tirzepatide regained 14% of their body weight over a year, while people who stayed on it lost another 5.5%.
  • People who regained less than 25% of the weight they had lost kept, on average, their improvements in waist size, cholesterol, fasting insulin and how well their body handles insulin.
  • The Zepbound label lists 5 mg, 10 mg and 15 mg once a week as maintenance doses, and stepping down to 5 mg protected against regain much better than stopping, though it held most of the loss for some people and not for others.
  • Metformin was not tested in the tirzepatide maintenance trials, so those trials cannot tell you whether metformin adds anything after tirzepatide, even though some sellers market it that way.
  • The researchers recommend stepping down with your clinical team, watching your weight, appetite and food noise in the first weeks, and going back up early if you need to.

Staying on tirzepatide is what kept weight off in the trials. People who stopped regained 14% of their body weight within a year, while people who kept taking it lost another 5.5% (SURMOUNT-4 trial in JAMA). Dropping to 5 mg held about two thirds of the loss on average, but fewer than half of people kept 80% or more of it (The Lancet on maintenance doses). Metformin was not part of those maintenance trials, so the evidence points to finding the dose of tirzepatide that holds your weight, not to adding a second pill.

What happens to your weight if you stop tirzepatide?

Weight comes back when you stop. In the SURMOUNT-4 trial, adults lost an average of 20.9% of their weight over 36 weeks on 10 or 15 mg of tirzepatide. Over the next 52 weeks, those switched to placebo regained 14% of their body weight. Those who stayed on tirzepatide lost another 5.5%.

Staying on it also took more people further. By week 88, 54.5% of the people who continued had lost at least 25% of their starting weight, compared with 5% of those switched to placebo.

The regain affects more than the number on the scale. In a follow-up analysis of SURMOUNT-4, people who regained more weight in the year after stopping lost more of their earlier improvements in waist size, blood pressure, non-HDL cholesterol, blood sugar and insulin resistance. Insulin resistance means your body needs more insulin to move sugar out of your blood.

Maintenance does not have to be perfect. People who regained less than 25% of what they had lost held on, on average, to their improvements in waist size, triglycerides, non-HDL cholesterol, fasting insulin and insulin resistance. The goal is holding most of the loss.

Is 5 mg of tirzepatide enough to keep weight off?

For some women it is, and for others it is not. The tirzepatide (Zepbound) label lists 5 mg, 10 mg and 15 mg once a week as maintenance doses for weight, with 15 mg once a week as the maximum. A lower dose is an approved option, not a workaround. The question is whether it holds your weight.

What you do after losing weight Trial What happened
Stop (switched to placebo) SURMOUNT-4 Regained 14% of body weight over 52 weeks
Stay on the highest dose you tolerate (10 or 15 mg) SURMOUNT-4 Lost another 5.5% over 52 weeks
Step down to 5 mg after weight plateaued SURMOUNT-MAINTAIN Kept an average of 67.9% of the weight lost. 42.4% kept at least 80% of their loss
Step down to 5 mg (whole 5 mg group) SURMOUNT-MAINTAIN 24.6% needed rescue tirzepatide because they regained at least half the weight they lost

The SURMOUNT-4 rows and the 5 mg rows come from different trials. Read them as what to expect from each choice, not as a head-to-head ranking.

Stepping down to 5 mg still protected against regain much better than switching to placebo (The Lancet). The researchers concluded that a fixed lower maintenance dose may be enough for some people but not enough for others. Your own dose is the one that keeps your weight where you want it.

Does adding metformin help keep weight off after tirzepatide?

The maintenance trials do not show that it does. Some telehealth sellers still market metformin as the way to hold your results after a GLP-1. Jently lists metformin at $117.00 and says it "acts as a metabolic anchor, helping to regulate insulin sensitivity and prevent the common rebound weight gain associated with ending treatment" (Jently's metformin page). That is a sales claim from the seller's own page.

The trial that showed weight staying off, SURMOUNT-4, compared tirzepatide with placebo, alongside diet and physical activity. Metformin was not the treatment being tested, so the trial cannot tell you whether metformin adds anything after tirzepatide.

The two drugs are often taken together by people with type 2 diabetes. In the SURPASS-3 trial, tirzepatide was added to metformin, with or without an SGLT2 inhibitor (another type of diabetes pill). Low blood sugar happened in 1% of people on 5 mg, 1% on 10 mg and 2% on 15 mg.

The label says tirzepatide can cause low blood sugar, including in adults without type 2 diabetes. The risk is higher if you also take insulin or a sulfonylurea, a pill that makes your body release more insulin. Tell your clinical team every medication you take, including anything another prescriber gave you for blood sugar.

Will your insulin sensitivity hold up on a lower dose?

It held up when weight held, so judge the dose by your weight. Tirzepatide's effect on insulin sensitivity goes beyond the weight you lose. In a 28-week trial of people with type 2 diabetes who were already taking metformin, tirzepatide 15 mg improved insulin sensitivity more than semaglutide 1 mg. The improvement was larger relative to the weight lost, so weight or fat loss alone did not explain it. This was a later analysis of a trial in people with diabetes, so it does not tell you what happens at a maintenance dose.

The maintenance data does speak to that. In the SURMOUNT-4 follow-up, people who regained less than 25% of their loss kept their gains in fasting insulin and insulin resistance on average. People who regained more lost more of those gains.

The practical upshot is to choose your dose by whether your weight holds, not by how low the number on the pen can go.

How do you find the right tirzepatide maintenance dose?

  1. Reach your plateau first. In SURMOUNT-MAINTAIN, people whose weight had plateaued before stepping down to 5 mg kept an average of 67.9% of their loss. One person on r/Zepbound describes the same handoff. In a thread titled "Slow and Steady wins the race," she wrote: "Next is leveling out and figuring out the right maintenance dose."
  2. Step down with your clinical team and watch for these signals. The researchers recommend watching how your weight moves in the first weeks, whether appetite or food noise comes back, how you feel on the dose and what you prefer. They also recommend going back up early if you need to.
  3. Expect the dose to change over time. The same r/Zepbound poster wrote about her weight-loss phase: "Experienced multiple stalls and increased dose when stall lasted about 4 weeks." Moving up or down is part of maintenance, not a sign you failed. The label caps the dose at 15 mg once a week.
  4. Tell your clinical team what rules tirzepatide out. It is not for women with a personal or family history of medullary thyroid cancer or MEN 2, an inherited condition that causes tumors in hormone glands. If you become pregnant, stop it. The label says weight loss offers no benefit during pregnancy and may harm the baby.

You worked hard for the weight you lost and want to keep it, along with the steadier blood sugar that came with it. Our clinical team can prescribe tirzepatide if it fits your goal and help you find a maintenance dose that holds your weight. Take the quiz to start a plan with our clinical team and find the tirzepatide dose that holds your results.

Ready to make a move?

Answer three questions to see the treatment options that fit your goals.

See My Plan

FAQ

How long do you have to stay on tirzepatide to keep the weight off?

In the trials, weight stayed off while people kept taking tirzepatide and came back after they stopped. In SURMOUNT-4, people switched to placebo regained 14% of their body weight over the next 52 weeks, while people who stayed on tirzepatide lost another 5.5%. The Zepbound label approves tirzepatide to maintain weight loss long term, so your clinical team can plan for ongoing treatment at a dose that holds your results.

What is the lowest maintenance dose of tirzepatide?

The lowest maintenance dose on the Zepbound label is 5 mg once a week, with 10 mg and 15 mg as the other options and 15 mg as the maximum. In SURMOUNT-MAINTAIN, people who stepped down to 5 mg after their weight plateaued kept an average of 67.9% of the weight they had lost. Only 42.4% kept at least 80% of their loss, so 5 mg is enough for some women and not for others.

Can you take metformin instead of tirzepatide after losing weight?

The maintenance trials do not show that metformin can replace tirzepatide for keeping weight off. Metformin was not the treatment tested in those trials, so they cannot tell you whether it adds anything after tirzepatide. What the trials do show is that staying on tirzepatide, at a dose that holds your weight, kept the weight off. Tell your clinical team every medication you take, including anything another prescriber gave you for blood sugar.

What should you do if weight creeps back on a maintenance dose?

Tell your clinical team early, because the researchers recommend going back up on the dose early if you need to. Watch how your weight moves in the first weeks after stepping down and whether appetite or food noise (constant thoughts about food) comes back. In SURMOUNT-MAINTAIN, 24.6% of the 5 mg group needed rescue tirzepatide, so moving the dose up is part of maintenance, not a sign you failed.

Keep reading

Sources (5)
  1. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial | Trials | JAMA | JAMA Network · jamanetwork.com · captured October 21, 2026
  2. Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 Trial | Trials | JAMA Internal Medicine | JAMA Network · jamanetwork.com · captured October 21, 2026
  3. Personalising maintenance after tirzepatide weight loss - The Lancet · thelancet.com · captured October 21, 2026
  4. Revised: 01/2026 · accessdata.fda.gov · captured October 21, 2026
  5. Metformin · jently.com · captured October 21, 2026